REG - Life Science REIT - Result of Meeting

Life Science ReitAnnouncement

24/11/2025 16:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251124:nRSX7865Ia&default-theme=true

RNS Number : 7865I  Life Science REIT PLC  24 November 2025

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE
OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A
VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

24 November 2025

 

Life Science REIT plc

(the "Company" or "LABS")

Result of General Meeting and Service of Protective Notice

 

On 4 November 2025, the Company announced the publication of a circular (the
"Circular") to convene a general meeting to allow Shareholders to consider
and, if thought fit, approve a change to the Company's investment objective
and policy in order to implement the recommended proposals for managed
wind-down of the Company.

The Board today announces that the ordinary resolution to adopt the New
Investment Objective and Investment Policy of the Company has been approved by
Shareholders.

Voting results of the General Meeting

The table below sets out the results of the vote at the General Meeting

                              Votes For (including discretionary)  Votes Against  Votes Total  Votes Withheld¹
 Number of Ordinary Shares    167,215,462                          920,924        168,136,386  191,130
 % of voted Ordinary Shares   99.45                                0.55           100.00       -
 % of total voting rights(2)  47.78                                0.26           48.04        -

 

(1) A vote withheld is not a vote in law and is not counted in the calculation
of the proportion of the votes for and against the ordinary resolution

(2) The number of Ordinary Shares in issue as at the voting record time of
6.30 p.m. (London time) on 20 November 2025 (the "Voting Record Time") was
350,000,000. As at that date no Ordinary Shares were held in treasury.
Therefore, the total number of voting rights in the Company as at the Voting
Record Time was 350,000,000.

Service of Protective Notice

The Board also announces that it served 2 years' protective notice to
terminate the investment advisory agreement entered into between the Company,
G10 Capital Limited and Ironstone Asset Management Limited, on the earliest
date upon which protective notice could have been served.

 

Unless otherwise defined, all capitalised terms used in this announcement have
the meanings given to them in the Circular.

The Company's LEI is 213800RG7JNX7K8F7525.

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

 Life Science REIT plc

 Claire Boyle, Chair                                                            via Panmure Liberum

 MUFG Corporate Governance Limited - Company Secretary

 labs_cosec@cm.mpms.mufg.com

 Panmure Liberum - Financial Adviser & Corporate Broker                         +44 20 7886 2500

 Tom Scrivens / Chris Clarke / Alex Collins / Ashwin Kohli

 G10 Capital Limited - AIFM                                                     +44 20 7397 5450

 Maria Baldwin

 FTI Consulting - PR Adviser

 Dido Laurimore / Richard Gotla / Oliver Parsons                                +44 20 3727 1000

 LifeScienceReit@fticonsulting.com (mailto:LifeScienceReit@fticonsulting.com)

 

 

The person responsible for arranging for the release of this announcement on
behalf of the Company is MUFG Corporate Governance Limited.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ROMFLFEELDLSFIE



            Copyright 2019 Regulatory News Service, all rights reserved